Show simple item record

dc.contributor.authorVan der Walt, Mietha M.
dc.contributor.authorTerre'Blanche, Gisella
dc.contributor.authorLourens, Anna C.U.
dc.contributor.authorPetzer, Anél
dc.contributor.authorPetzer, Jacobus P.
dc.date.accessioned2014-01-09T08:12:29Z
dc.date.available2014-01-09T08:12:29Z
dc.date.issued2012
dc.identifier.citationVan der Walt, M.M. et al. 2012. Sulfanylphthalonitrile analogues as selective and potent inhibitors of monoamine oxidase B. Bioorganic & medicinal chemistry letters, 22(24):7367-7370. [https://doi.org/10.1016/j.bmcl.2012.10.070]en_US
dc.identifier.issn0960-894X
dc.identifier.issn1464-3405 (Online)
dc.identifier.urihttp://hdl.handle.net/10394/9893
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0960894X12013613
dc.identifier.urihttps://doi.org/10.1016/j.bmcl.2012.10.070
dc.description.abstractIt has recently been reported that nitrile containing compounds frequently act as potent monoamine oxidase B (MAO-B) inhibitors. Modelling studies suggest that this high potency inhibition may rely, at least in part, on polar interactions between nitrile functional groups and polar moieties within the MAO-B substrate cavity. In an attempt to identify potent and selective inhibitors of MAO-B and to contribute to the known structure–activity relationships of MAO inhibition by nitrile containing compounds, the present study examined the MAO inhibitory properties of series of novel sulfanylphthalonitriles and sulfanylbenzonitriles. The results document that the evaluated compounds are potent and selective MAO-B inhibitors with most homologues possessing IC50 values in the nanomolar range. In general, the sulfanylphthalonitriles exhibited higher binding affinities for MAO-B than the corresponding sulfanylbenzonitrile homologues. Among the compounds evaluated, 4-[(4-bromobenzyl)sulfanyl]phthalonitrile is a particularly promising inhibitor since it displayed a high degree of selectivity (8720-fold) for MAO-B over MAO-A, and potent MAO-B inhibition (IC50 = 0.025 μM). Based on these observations, this structure may serve as a lead for the development of therapies for neurodegenerative disorders such as Parkinson’s disease.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectPhthalonitrileen_US
dc.subjectBenzonitrileen_US
dc.subjectMonoamine oxidaseen_US
dc.subjectMAOen_US
dc.subjectInhibitionen_US
dc.subjectParkinson’s diseaseen_US
dc.titleSulfanylphthalonitrile analogues as selective and potent inhibitors of monoamine oxidase Ben_US
dc.typeArticleen_US
dc.contributor.researchID10206280 - Terre'Blanche, Gisella
dc.contributor.researchID10948724 - Lourens, Anna Catharina U.
dc.contributor.researchID12264954 - Petzer, Anél
dc.contributor.researchID10727388 - Petzer, Jacobus Petrus
dc.contributor.researchID13035134 - Van der Walt, Mietha Magdalena


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record